Last reviewed · How we verify

NCT06342973

Horizontal Ridge Augmentation With Demineralized Bone Allograft Layered With Xenograft - a Prospective Clinical Study

Completed Phase 4 Last updated 21 November 2025
What this trial tests

Phase 4 trial testing Xenograft and allograft in Alveolar Ridge Deficiency in 15 participants. Completed in 15 October 2025.

Timeline
27 March 2024
Primary endpoint
15 October 2025
15 October 2025

Quick facts

Lead sponsorLouisiana State University Health Sciences Center in New Orleans
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment15
Start date27 March 2024
Primary completion15 October 2025
Estimated completion15 October 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Louisiana State University Health Sciences Center in New Orleans

Who can join

18 and older, any sex, with Alveolar Ridge Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this case series is to evaluate the outcomes of horizontal ridge augmentation performed using a combination of demineralized freeze-dried bone allograft layered with xenograft bone with a resorbable native collagen membrane.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Louisiana State University Health Sciences Center in New Orleans trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06342973.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing